Recombinant Human MUC13 Protein，His

MUC13 is a member of the mucin family of glycoproteins, which are heavily glycosylated proteins playing crucial roles in cellular processes such as signaling, adhesion, and protection. It is primarily expressed in epithelial tissues and has been found to be upregulated in various cancers, including pancreatic, gastric, and colorectal cancers. This aberrant expression suggests that MUC13 may contribute to tumorigenesis, and it has garnered attention as a potential biomarker for cancer diagnosis and a target for therapeutic intervention. Recent studies have indicated that MUC13 is involved in important cellular pathways, including inflammation, cell proliferation, and the epithelial-to-mesenchymal transition (EMT), which is critical for cancer metastasis. To further explore the functional roles and mechanisms of MUC13 in cancer biology, researchers have focused on the production and characterization of recombinant MUC13 protein. This recombinant protein serves as a valuable tool for studying its structure, glycosylation patterns, and interactions with other cellular molecules. Understanding these aspects of MUC13 could lead to deeper insights into its role in cancer progression and may aid in the development of targeted therapies. Additionally, the recombinant MUC13 protein can be utilized in various experimental settings, including cell-based assays and antibody generation, to facilitate research aimed at uncovering its biological significance and potential clinical applications. Overall, the study of MUC13 and its recombinant forms presents a promising avenue for advancing cancer research and improving therapeutic strategies.